Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Catalyst Pharmaceuticals (CPRX) Inventory Average (2019 - 2025)

Historic Inventory Average for Catalyst Pharmaceuticals (CPRX) over the last 7 years, with Q3 2025 value amounting to $23.3 million.

  • Catalyst Pharmaceuticals' Inventory Average rose 2273.93% to $23.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.3 million, marking a year-over-year increase of 2273.93%. This contributed to the annual value of $17.6 million for FY2024, which is 5673.3% up from last year.
  • Per Catalyst Pharmaceuticals' latest filing, its Inventory Average stood at $23.3 million for Q3 2025, which was up 2273.93% from $19.2 million recorded in Q2 2025.
  • In the past 5 years, Catalyst Pharmaceuticals' Inventory Average ranged from a high of $23.3 million in Q3 2025 and a low of $4.5 million during Q1 2021
  • Its 5-year average for Inventory Average is $12.3 million, with a median of $9.9 million in 2023.
  • In the last 5 years, Catalyst Pharmaceuticals' Inventory Average soared by 18438.36% in 2021 and then tumbled by 595.82% in 2022.
  • Over the past 5 years, Catalyst Pharmaceuticals' Inventory Average (Quarter) stood at $7.4 million in 2021, then dropped by 5.96% to $7.0 million in 2022, then soared by 77.08% to $12.3 million in 2023, then surged by 60.29% to $19.8 million in 2024, then grew by 18.0% to $23.3 million in 2025.
  • Its last three reported values are $23.3 million in Q3 2025, $19.2 million for Q2 2025, and $19.7 million during Q1 2025.